# Atea Pharmaceuticals, Inc.: filings

AVIR · Nasdaq · CIK 1593899 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/avir.md) · [Financials](/companies/avir/financials.md) · [Filings](/companies/avir/filings.md) · [Insiders](/companies/avir/insiders.md)

## Reports and events: 83 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 106, 8-K 41, SC 13G/A 25, 3 19, 10-Q 18, DEFA14A 13, 144 12, SC 13G 10, 10-K 6, DEF 14A 6, SCHEDULE 13G/A 6, CORRESP 4, D 4, EFFECT 3, SC 13D/A 3, UPLOAD 3, 4/A 2, D/A 2, POS AM 2, S-1/A 2, S-8 2, SC 13D 2, SCHEDULE 13D 2, SCHEDULE 13D/A 2, SCHEDULE 13G 2, SEC STAFF LETTER 2, 424B4 1, 8-A12B 1, ARS 1, CERT 1, DFAN14A 1, DRS 1, DRS/A 1, DRSLTR 1, POSASR 1, S-1 1, S-1MEF 1, S-3 1, S-3ASR 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-08-12 | 20:45 ET | [10-Q](/filings/0001193125-26-347021.md) | Quarterly report, period 2026-06-30 | 0001193125-26-347021 |
| 2026-08-12 | 20:15 ET | [8-K](/filings/0001193125-26-346888.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-346888 |
| 2026-06-22 | 20:53 ET | [8-K](/filings/0001193125-26-277639.md) | 5.07 Shareholder vote results | 0001193125-26-277639 |
| 2026-05-12 | 20:45 ET | [10-Q](/filings/0001193125-26-219678.md) | Quarterly report, period 2026-03-31 | 0001193125-26-219678 |
| 2026-05-12 | 20:17 ET | [8-K](/filings/0001193125-26-219507.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-219507 |
| 2026-04-27 | 20:45 ET | [DEF 14A](/filings/0001193125-26-182293.md) | Proxy statement, period 2026-06-18 | 0001193125-26-182293 |
| 2026-03-05 | 21:50 ET | [10-K](/filings/0001193125-26-094159.md) | Annual report, period 2025-12-31 | 0001193125-26-094159 |
| 2026-03-05 | 21:11 ET | [8-K](/filings/0001193125-26-093961.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-093961 |
| 2026-01-08 | 14:05 ET | [8-K](/filings/0001193125-26-007081.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-007081 |
| 2025-11-12 | 21:45 ET | [10-Q](/filings/0001193125-25-277815.md) | Quarterly report, period 2025-09-30 | 0001193125-25-277815 |
| 2025-11-12 | 21:16 ET | [8-K](/filings/0001193125-25-277627.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-277627 |
| 2025-08-07 | 20:35 ET | [10-Q](/filings/0000950170-25-105123.md) | Quarterly report, period 2025-06-30 | 0000950170-25-105123 |
| 2025-08-07 | 20:11 ET | [8-K](/filings/0001193125-25-175433.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-175433 |
| 2025-06-20 | 21:16 ET | [8-K](/filings/0001193125-25-143750.md) | 5.07 Shareholder vote results | 0001193125-25-143750 |
| 2025-05-12 | 20:45 ET | [10-Q](/filings/0000950170-25-069367.md) | Quarterly report, period 2025-03-31 | 0000950170-25-069367 |
| 2025-05-12 | 20:23 ET | [8-K](/filings/0001193125-25-117809.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-117809 |
| 2025-04-29 | 21:00 ET | [DEF 14A](/filings/0001193125-25-104019.md) | Proxy statement, period 2025-06-20 | 0001193125-25-104019 |
| 2025-04-17 | 16:23 ET | [SCHEDULE 13D/A](/filings/0000921895-25-001112.md) | Ownership report, active investor, amended | 0000921895-25-001112 |
| 2025-04-17 | 12:06 ET | [8-K](/filings/0001193125-25-083523.md) | 1.01 Entry into a material agreement; 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-083523 |
| 2025-04-01 | 13:19 ET | [8-K](/filings/0001193125-25-069932.md) | 8.01 Other events | 0001193125-25-069932 |
| 2025-03-24 | 10:10 ET | [8-K](/filings/0001193125-25-060794.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-060794 |
| 2025-03-21 | 15:58 ET | [SCHEDULE 13D/A](/filings/0000921895-25-000843.md) | Ownership report, active investor, amended | 0000921895-25-000843 |
| 2025-03-06 | 21:45 ET | [10-K](/filings/0000950170-25-034808.md) | Annual report, period 2024-12-31 | 0000950170-25-034808 |
| 2025-03-06 | 21:16 ET | [8-K](/filings/0001193125-25-048426.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-048426 |
| 2025-03-04 | 14:27 ET | [SCHEDULE 13D](/filings/0000921895-25-000684.md) | Ownership report, active investor | 0000921895-25-000684 |
| 2025-02-24 | 13:17 ET | [8-K](/filings/0001193125-25-032826.md) | 5.02 Departure or appointment of officers or directors | 0001193125-25-032826 |
| 2025-01-14 | 23:54 ET | [8-K](/filings/0001193125-25-005424.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-005424 |
| 2024-12-16 | 14:50 ET | [SCHEDULE 13D](/filings/0001373604-24-000114.md) | Ownership report, active investor | 0001373604-24-000114 |
| 2024-11-07 | 21:41 ET | [10-Q](/filings/0000950170-24-123447.md) | Quarterly report, period 2024-09-30 | 0000950170-24-123447 |
| 2024-11-07 | 21:27 ET | [8-K](/filings/0001193125-24-253143.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-24-253143 |
| 2024-08-07 | 20:45 ET | [10-Q](/filings/0000950170-24-092914.md) | Quarterly report, period 2024-06-30 | 0000950170-24-092914 |
| 2024-08-07 | 20:15 ET | [8-K](/filings/0001193125-24-195895.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-24-195895 |
| 2024-06-21 | 21:21 ET | [8-K](/filings/0001193125-24-165886.md) | 5.07 Shareholder vote results | 0001193125-24-165886 |
| 2024-05-14 | 20:43 ET | [10-Q](/filings/0000950170-24-059699.md) | Quarterly report, period 2024-03-31 | 0000950170-24-059699 |
| 2024-05-14 | 20:16 ET | [8-K](/filings/0001193125-24-138249.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-24-138249 |
| 2024-04-26 | 20:21 ET | [DEF 14A](/filings/0000950170-24-049178.md) | Proxy statement, period 2024-06-21 | 0000950170-24-049178 |
| 2024-02-28 | 22:00 ET | [10-K](/filings/0000950170-24-022226.md) | Annual report, period 2023-12-31 | 0000950170-24-022226 |
| 2024-02-28 | 21:18 ET | [8-K](/filings/0001193125-24-050724.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-24-050724 |
| 2023-11-28 | 11:00 ET | [SC 13D/A](/filings/0001214659-23-015585.md) | Ownership report, active investor, amended | 0001214659-23-015585 |
| 2023-11-08 | 21:43 ET | [10-Q](/filings/0000950170-23-061213.md) | Quarterly report, period 2023-09-30 | 0000950170-23-061213 |
| 2023-11-08 | 21:15 ET | [8-K](/filings/0001193125-23-273532.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-23-273532 |
| 2023-08-08 | 20:46 ET | [10-Q](/filings/0000950170-23-039920.md) | Quarterly report, period 2023-06-30 | 0000950170-23-039920 |
| 2023-08-08 | 20:21 ET | [8-K](/filings/0001193125-23-206247.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-23-206247 |
| 2023-06-21 | 21:02 ET | [8-K](/filings/0001193125-23-171257.md) | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-23-171257 |
| 2023-05-22 | 13:00 ET | [SC 13D](/filings/0001214659-23-007616.md) | Ownership report, active investor | 0001214659-23-007616 |
| 2023-05-08 | 20:41 ET | [10-Q](/filings/0000950170-23-018869.md) | Quarterly report, period 2023-03-31 | 0000950170-23-018869 |
| 2023-05-08 | 20:15 ET | [8-K](/filings/0001193125-23-138257.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-23-138257 |
| 2023-04-28 | 20:07 ET | [DEF 14A](/filings/0000950170-23-015773.md) | Proxy statement | 0000950170-23-015773 |
| 2023-02-28 | 21:56 ET | [10-K](/filings/0000950170-23-005186.md) | Annual report, period 2022-12-31 | 0000950170-23-005186 |
| 2023-02-28 | 21:12 ET | [8-K](/filings/0001193125-23-053843.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-23-053843 |

Page 1 of 2. [Older](/companies/avir/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:14 ET. No prices; not investment advice.